AKT1 and cancer: Magnolol inactivated the tyrosine kinase receptor EGFR and VEGFR2 [14,50] as well as upregulating PTEN activity, thereby abolishing the abnormal PI3K/Akt/mTOR signaling in cancer cells [38,58].